{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T02:40:13Z","timestamp":1742524813540,"version":"3.40.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02701-1","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T02:10:00Z","timestamp":1742523000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increase of VEGF and Fibronectin expression and ultrastructural alterations of intercellular junctions in a swab negative patient after SARS-COV-2 infection"],"prefix":"10.1186","volume":"22","author":[{"given":"Carolina","family":"Simioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana Maria","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Gaf\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Cenacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savino","family":"Occhionorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca Maria","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2701_CR1","doi-asserted-by":"crossref","first-page":"560616","DOI":"10.3389\/fcimb.2020.560616","volume":"10","author":"KU Islam","year":"2020","unstructured":"Islam KU, Iqbal J. An update on molecular diagnostics for COVID-19. Front Cell Infect Microbiol. 2020;10:560616.","journal-title":"Front Cell Infect Microbiol"},{"key":"2701_CR2","doi-asserted-by":"crossref","first-page":"e3303","DOI":"10.1002\/jgm.3303","volume":"23","author":"M Mohamadian","year":"2021","unstructured":"Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: virology, biology and novel laboratory diagnosis. J Gene Med. 2021;23:e3303.","journal-title":"J Gene Med"},{"key":"2701_CR3","doi-asserted-by":"crossref","unstructured":"Chen TH, Hsu MT, Lee MY, Chou CK. Gastrointestinal involvement in SARS-CoV-2 infection. Viruses. 2022;14.","DOI":"10.3390\/v14061188"},{"key":"2701_CR4","first-page":"39","volume":"13","author":"B Hossain","year":"2023","unstructured":"Hossain B, Malik F, Khan A, Abidi M, Marhaba A, Oranu A, et al. Prevalence and impact of Gastrointestinal manifestations in COVID-19 patients: A systematic review. J Community Hosp Intern Med Perspect. 2023;13:39\u201354.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2701_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-022-00986-0","volume":"7","author":"B Wang","year":"2022","unstructured":"Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, Zhang L. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022;7:143.","journal-title":"Signal Transduct Target Ther"},{"key":"2701_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/physiolgenomics.00087.2020","volume":"53","author":"UM Ashraf","year":"2021","unstructured":"Ashraf UM, Abokor AA, Edwards JM, Waigi EW, Royfman RS, Hasan SA, et al. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol Genomics. 2021;53:51\u201360.","journal-title":"Physiol Genomics"},{"key":"2701_CR7","doi-asserted-by":"crossref","first-page":"e21969","DOI":"10.1096\/fj.202100821RRR","volume":"35","author":"D Bortolotti","year":"2021","unstructured":"Bortolotti D, Simioni C, Neri LM, Rizzo R, Semprini CM, Occhionorelli S, et al. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage. FASEB J. 2021;35:e21969.","journal-title":"FASEB J"},{"key":"2701_CR8","first-page":"11","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7:11.","journal-title":"Mil Med Res"},{"key":"2701_CR9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cmi.2021.01.012","volume":"27","author":"R Rizzo","year":"2021","unstructured":"Rizzo R, Neri LM, Simioni C, Bortolotti D, Occhionorelli S, Zauli G, et al. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient. Clin Microbiol Infect. 2021;27:936\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"2701_CR10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/joim.13385","volume":"291","author":"P Zamboni","year":"2022","unstructured":"Zamboni P, Bortolotti D, Occhionorelli S, Traina L, Neri LM, Rizzo R, et al. Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab. J Intern Med. 2022;291:224\u201331.","journal-title":"J Intern Med"},{"key":"2701_CR11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"F Qi","year":"2020","unstructured":"Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526:135\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"2701_CR12","doi-asserted-by":"crossref","unstructured":"Zamboni P. COVID-19 as a vascular disease: lesson learned from imaging and blood biomarkers. Diagnostics (Basel). 2020;10:440.","DOI":"10.3390\/diagnostics10070440"},{"key":"2701_CR13","doi-asserted-by":"crossref","unstructured":"Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial damage in acute respiratory distress syndrome. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21228793"},{"key":"2701_CR14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jth.15339","volume":"19","author":"DM Smadja","year":"2021","unstructured":"Smadja DM, Philippe A, Bory O, Gendron N, Beauvais A, Gruest M, et al. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021;19:1823\u201330.","journal-title":"J Thromb Haemost"},{"key":"2701_CR15","doi-asserted-by":"crossref","first-page":"e14844","DOI":"10.15252\/emmm.202114844","volume":"14","author":"FM Zeng","year":"2022","unstructured":"Zeng FM, Li YW, Deng ZH, He JZ, Li W, Wang L, et al. SARS-CoV-2 Spike Spurs intestinal inflammation via VEGF production in enterocytes. EMBO Mol Med. 2022;14:e14844.","journal-title":"EMBO Mol Med"},{"key":"2701_CR16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/21541248.2020.1809927","volume":"12","author":"A Sundararaman","year":"2021","unstructured":"Sundararaman A, Mellor H. A functional antagonism between RhoJ and Cdc42 regulates fibronectin remodelling during angiogenesis. Small GTPases. 2021;12:241\u20135.","journal-title":"Small GTPases"},{"key":"2701_CR17","first-page":"331","volume":"122","author":"F Sarpdag","year":"2021","unstructured":"Sarpdag F, Yonem O, Aktas A, Seckin Y, Tuncer E, Ozer H. Colonic fibronectin and E-cadherin in mild ulcerative colitis. Bratisl Lek Listy. 2021;122:331\u20135.","journal-title":"Bratisl Lek Listy"},{"key":"2701_CR18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/15476286.2022.2100629","volume":"19","author":"C Eyileten","year":"2022","unstructured":"Eyileten C, Wicik Z, Simoes SN, Martins-Jr DC, Klos K, Wlodarczyk W, et al. Thrombosis-related Circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19. RNA Biol. 2022;19:963\u201379.","journal-title":"RNA Biol"},{"key":"2701_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cels.2020.10.003","volume":"12","author":"KA Overmyer","year":"2021","unstructured":"Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, et al. Large-Scale Multi-omic analysis of COVID-19 severity. Cell Syst. 2021;12:23\u201340. e7.","journal-title":"Cell Syst"},{"key":"2701_CR20","doi-asserted-by":"crossref","unstructured":"Lemanska-Perek A, Krzyzanowska-Golab D, Dragan B, Tyszko M, Adamik B. Fibronectin as a marker of disease severity in critically ill COVID-19 patients. Cells. 2022;11.","DOI":"10.3390\/cells11091566"},{"key":"2701_CR21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5501\/wjv.v12.i2.68","volume":"12","author":"EP Tsounis","year":"2023","unstructured":"Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J Virol. 2023;12:68\u201390.","journal-title":"World J Virol"},{"key":"2701_CR22","doi-asserted-by":"crossref","unstructured":"Simioni C, Sanz JM, Gafa R, Tagliatti V, Greco P, Passaro A, Neri LM. Effects of SARS-COV-2 on molecules involved in vascularization and autophagy in placenta tissues. J Mol Histol. 2024;55:753\u2013764.","DOI":"10.1007\/s10735-024-10228-y"},{"key":"2701_CR23","doi-asserted-by":"crossref","unstructured":"Karakasis P, Nasoufidou A, Sagris M, Fragakis N, Tsioufis K. Vascular alterations following COVID-19 infection: A comprehensive literature review. Life (Basel). 2024;14:545.","DOI":"10.3390\/life14050545"},{"key":"2701_CR24","doi-asserted-by":"crossref","first-page":"107602962093814","DOI":"10.1177\/1076029620938149","volume":"26","author":"W Miesbach","year":"2020","unstructured":"Miesbach W, Makris M. COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost. 2020;26:1076029620938149.","journal-title":"Clin Appl Thromb Hemost"},{"key":"2701_CR25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089\u201398.","journal-title":"Intensive Care Med"},{"key":"2701_CR26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834\u201347.","journal-title":"Am J Hematol"},{"key":"2701_CR27","doi-asserted-by":"crossref","first-page":"826218","DOI":"10.3389\/fmed.2022.826218","volume":"9","author":"F Maldonado","year":"2022","unstructured":"Maldonado F, Morales D, Diaz-Papapietro C, Valdes C, Fernandez C, Valls N, et al. Relationship between endothelial and angiogenesis biomarkers envisage mortality in a prospective cohort of COVID-19 patients requiring respiratory support. Front Med (Lausanne). 2022;9:826218.","journal-title":"Front Med (Lausanne)"},{"key":"2701_CR28","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1007\/s11033-020-05831-7","volume":"47","author":"S Meini","year":"2020","unstructured":"Meini S, Giani T, Tascini C. Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2. Mol Biol Rep. 2020;47:8301\u20134.","journal-title":"Mol Biol Rep"},{"key":"2701_CR29","doi-asserted-by":"crossref","first-page":"1282471","DOI":"10.3389\/fgene.2024.1282471","volume":"15","author":"H Lin","year":"2024","unstructured":"Lin H, Cao B. Circulating VEGF and inflammatory bowel disease: a bidirectional Mendelian randomization. Front Genet. 2024;15:1282471.","journal-title":"Front Genet"},{"key":"2701_CR30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10753-020-01378-8","volume":"44","author":"L Wang","year":"2021","unstructured":"Wang L, Wang S, Xue A, Shi J, Zheng C, Huang Y. Thalidomide inhibits angiogenesis via downregulation of VEGF and Angiopoietin-2 in Crohn\u2019s disease. Inflammation. 2021;44:795\u2013807.","journal-title":"Inflammation"},{"key":"2701_CR31","first-page":"1339","volume":"58","author":"RB Mateescu","year":"2017","unstructured":"Mateescu RB, Bastian AE, Nichita L, Marinescu M, Rouhani F, Voiosu AM, et al. Vascular endothelial growth factor - key mediator of angiogenesis and promising therapeutical target in ulcerative colitis. Rom J Morphol Embryol. 2017;58:1339\u201345.","journal-title":"Rom J Morphol Embryol"},{"key":"2701_CR32","doi-asserted-by":"crossref","first-page":"718356","DOI":"10.3389\/fnut.2021.718356","volume":"8","author":"G Barbara","year":"2021","unstructured":"Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, et al. Inflammatory and Microbiota-Related regulation of the intestinal epithelial barrier. Front Nutr. 2021;8:718356.","journal-title":"Front Nutr"},{"key":"2701_CR33","doi-asserted-by":"crossref","unstructured":"Assimakopoulos SF, Eleftheriotis G, Lagadinou M, Karamouzos V, Dousdampanis P, Siakallis G, Marangos M. SARS CoV-2-Induced viral sepsis: the role of gut barrier dysfunction. Microorganisms. 2022;10:1050.","DOI":"10.3390\/microorganisms10051050"},{"key":"2701_CR34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.aat0835","volume":"359","author":"S Citi","year":"2018","unstructured":"Citi S. Intestinal barriers protect against disease. Science. 2018;359:1097\u20138.","journal-title":"Science"},{"key":"2701_CR35","doi-asserted-by":"crossref","first-page":"1129190","DOI":"10.3389\/fimmu.2023.1129190","volume":"14","author":"G Eleftheriotis","year":"2023","unstructured":"Eleftheriotis G, Tsounis EP, Aggeletopoulou I, Dousdampanis P, Triantos C, Mouzaki A, et al. Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential. Front Immunol. 2023;14:1129190.","journal-title":"Front Immunol"},{"key":"2701_CR36","doi-asserted-by":"crossref","first-page":"1303356","DOI":"10.3389\/fimmu.2024.1303356","volume":"15","author":"Y Luo","year":"2024","unstructured":"Luo Y, Zhang Z, Ren J, Dou C, Wen J, Yang Y, et al. SARS-Cov-2 Spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9. Front Immunol. 2024;15:1303356.","journal-title":"Front Immunol"},{"key":"2701_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jphs.2022.04.010","volume":"149","author":"S Yamada","year":"2022","unstructured":"Yamada S, Noda T, Okabe K, Yanagida S, Nishida M, Kanda Y. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium. J Pharmacol Sci. 2022;149:139\u201346.","journal-title":"J Pharmacol Sci"},{"key":"2701_CR38","doi-asserted-by":"crossref","first-page":"1127529","DOI":"10.3389\/fmed.2023.1127529","volume":"10","author":"S Greco","year":"2023","unstructured":"Greco S, Sanz JM, Bortolotti D, Semprini CM, Braga C, Gafa R, et al. Case report: tissue positivity for SARS-CoV-2 in a preterm born infant death of thrombosis: possible intrauterine transmission. Front Med (Lausanne). 2023;10:1127529.","journal-title":"Front Med (Lausanne)"},{"key":"2701_CR39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1473-3099(24)00171-3","volume":"24","author":"W Zuo","year":"2024","unstructured":"Zuo W, He D, Liang C, Du S, Hua Z, Nie Q, et al. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. Lancet Infect Dis. 2024;24:845\u201355.","journal-title":"Lancet Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02701-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02701-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02701-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T02:10:25Z","timestamp":1742523025000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02701-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2701"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02701-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical principles for medical research involving human subjects as required by the 2013 revision of the Helsinki Declaration\u2014WMA Declaration of Helsinki\u2014The Ethical Principles for Medical Research Involving Human Subjects. The Local Ethics Committee (Comitato Etico di Area Vasta Emilia Centro della Regione Emilia-Romagna, CE-AVEC) approved this study (reference number 122\/2021\/Oss\/AOUFe). The participant has signed informed consent to be included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Published images cannot be linked to the patient in any way.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}